MARKET

IBB

IBB

iShares Biotechnology ETF
NASDAQ
132.73
-2.10
-1.56%
After Hours: 132.99 +0.26 +0.20% 17:45 01/10 EST
OPEN
133.54
PREV CLOSE
134.83
HIGH
133.81
LOW
131.76
VOLUME
2.77M
TURNOVER
--
52 WEEK HIGH
150.29
52 WEEK LOW
123.37
TOTAL ASSET
6.34B
YTD YIELD
-3.66%
1D
5D
1M
3M
1Y
5Y
1D
Strong December Jobs Supports Strong S&P 500 Earnings, But Maybe Not A Big Year For Stock Returns
Seeking Alpha · 2d ago
TD Cowen's Investment Themes For 2025: Spotting Opportunities And Risks
Seeking Alpha · 2d ago
We Asked Retail If Novavax Stock Is A Buy At Current Levels: Nearly 70% Think It's Undervalued
Barchart · 3d ago
Q1 2025 Equity Market Outlook
Seeking Alpha · 4d ago
Avadel Pharmaceuticals Misses Earnings Estimates But Posts 150% Sales Increase From Narcolepsy Drug LUMRYZ
Benzinga · 4d ago
Top 5 Commercial Biotech Buyout Candidates: Day One Biopharmaceuticals (No. 5)
Seeking Alpha · 5d ago
Weekly Report: what happened at IBB last week (1230-0103)?
Weekly Report · 01/06 10:27
Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now?
NASDAQ · 01/02 11:20
More
Profile
Fund Name
iShares Biotechnology ETF
Inception Date
2001-02-05
Benchmark
ICE Biotechnology TR USD
Advisor Company
iShares
Custodian
JPMorgan Chase Bank, N.A.
Manager
Greg Savage, Jennifer Hsui, Amy Whitelaw, Paul Whitehead